** Shares of some U.S. drugmakers fall premarket, amid a broader market sell-off, after U.S. President Donald Trump threatened steep tariffs on the sector
** The pharma sector had briefly ducked Trump's sweeping tariffs announcement on Wednesday, but some of the stocks have wiped off gains from the previous session after he said the sector was under review
** Shares of Merck MRK.N down 1.6%, Biogen BIIB.O down 1.3%, Pfizer PFE.N down 2% and Eli Lilly LLY.N down 3% before the bell
** MRK, AbbVie ABBV.N and Amgen AMGN.O climbed between 2% and 3% on Thursday
** Up to last close, LLY up 2.2% , MRK down 13.2%, BIIB down 14.5% and PFE down 8.4% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.